SURAMIN - IS ADAPTIVE-CONTROL NECESSARY

被引：3

作者：

KOBAYASHI, K

VOKES, EE

STEFANSSON, K

JANISCH, L

VOGELZANG, NJ

BEREZIN, F

RATAIN, MJ

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1992年 / 10卷 / 12期

关键词：

D O I：

10.1200/JCO.1992.10.12.1984

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1984 / 1985

页数：2

相关论文

共 3 条

[1] SURAMIN, AN EXPERIMENTAL CHEMOTHERAPEUTIC DRUG, ACTIVATES THE RECEPTOR FOR EPIDERMAL GROWTH-FACTOR AND PROMOTES GROWTH OF CERTAIN MALIGNANT-CELLS [J].

CARDINALI, M ;

SARTOR, O ;

ROBBINS, KC .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1242-1247

[2]

LAROCCA RV, 1990, NEUROLOGY, V40, P954

[3] SURAMIN - A NOVEL GROWTH-FACTOR ANTAGONIST WITH ACTIVITY IN HORMONE-REFRACTORY METASTATIC PROSTATE-CANCER [J].

MYERS, C ;

COOPER, M ;

STEIN, C ;

LAROCCA, R ;

WALTHER, MM ;

WEISS, G ;

CHOYKE, P ;

DAWSON, N ;

STEINBERG, S ;

UHRICH, MM ;

CASSIDY, J ;

KOHLER, DR ;

TREPEL, J ;

LINEHAN, WM .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (06) :881-889